Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C16H16ClNO2S |
Molecular Weight | 321.822 |
Optical Activity | ( + ) |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=CC=CC=C3Cl
InChI
InChIKey=GKTWGGQPFAXNFI-HNNXBMFYSA-N
InChI=1S/C16H16ClNO2S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14/h2-5,7,9,15H,6,8,10H2,1H3/t15-/m0/s1
Molecular Formula | C16H16ClNO2S |
Molecular Weight | 321.822 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:42:51 UTC 2023
by
admin
on
Sat Dec 16 17:42:51 UTC 2023
|
Record UNII |
A74586SNO7
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000008832
Created by
admin on Sat Dec 16 17:42:55 UTC 2023 , Edited by admin on Sat Dec 16 17:42:55 UTC 2023
|
||
|
WHO-VATC |
QB01AC04
Created by
admin on Sat Dec 16 17:42:55 UTC 2023 , Edited by admin on Sat Dec 16 17:42:55 UTC 2023
|
||
|
WHO-ATC |
B01AC04
Created by
admin on Sat Dec 16 17:42:55 UTC 2023 , Edited by admin on Sat Dec 16 17:42:55 UTC 2023
|
||
|
NCI_THESAURUS |
C80483
Created by
admin on Sat Dec 16 17:42:55 UTC 2023 , Edited by admin on Sat Dec 16 17:42:55 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL ACINO (AUTHORIZED:ACUTE CORONARY SYNDROME)
Created by
admin on Sat Dec 16 17:42:55 UTC 2023 , Edited by admin on Sat Dec 16 17:42:55 UTC 2023
|
||
|
NDF-RT |
N0000008832
Created by
admin on Sat Dec 16 17:42:55 UTC 2023 , Edited by admin on Sat Dec 16 17:42:55 UTC 2023
|
||
|
NDF-RT |
N0000182142
Created by
admin on Sat Dec 16 17:42:55 UTC 2023 , Edited by admin on Sat Dec 16 17:42:55 UTC 2023
|
||
|
NDF-RT |
N0000175578
Created by
admin on Sat Dec 16 17:42:55 UTC 2023 , Edited by admin on Sat Dec 16 17:42:55 UTC 2023
|
||
|
LIVERTOX |
NBK547946
Created by
admin on Sat Dec 16 17:42:55 UTC 2023 , Edited by admin on Sat Dec 16 17:42:55 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL ACINO (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by
admin on Sat Dec 16 17:42:55 UTC 2023 , Edited by admin on Sat Dec 16 17:42:55 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL1771
Created by
admin on Sat Dec 16 17:42:55 UTC 2023 , Edited by admin on Sat Dec 16 17:42:55 UTC 2023
|
PRIMARY | |||
|
C055162
Created by
admin on Sat Dec 16 17:42:55 UTC 2023 , Edited by admin on Sat Dec 16 17:42:55 UTC 2023
|
PRIMARY | |||
|
DB00758
Created by
admin on Sat Dec 16 17:42:55 UTC 2023 , Edited by admin on Sat Dec 16 17:42:55 UTC 2023
|
PRIMARY | |||
|
100000091166
Created by
admin on Sat Dec 16 17:42:55 UTC 2023 , Edited by admin on Sat Dec 16 17:42:55 UTC 2023
|
PRIMARY | |||
|
7430
Created by
admin on Sat Dec 16 17:42:55 UTC 2023 , Edited by admin on Sat Dec 16 17:42:55 UTC 2023
|
PRIMARY | |||
|
m3655
Created by
admin on Sat Dec 16 17:42:55 UTC 2023 , Edited by admin on Sat Dec 16 17:42:55 UTC 2023
|
PRIMARY | Merck Index | ||
|
113665-84-2
Created by
admin on Sat Dec 16 17:42:55 UTC 2023 , Edited by admin on Sat Dec 16 17:42:55 UTC 2023
|
PRIMARY | |||
|
CLOPIDOGREL
Created by
admin on Sat Dec 16 17:42:55 UTC 2023 , Edited by admin on Sat Dec 16 17:42:55 UTC 2023
|
PRIMARY | |||
|
5908
Created by
admin on Sat Dec 16 17:42:55 UTC 2023 , Edited by admin on Sat Dec 16 17:42:55 UTC 2023
|
PRIMARY | |||
|
758613
Created by
admin on Sat Dec 16 17:42:55 UTC 2023 , Edited by admin on Sat Dec 16 17:42:55 UTC 2023
|
PRIMARY | |||
|
N0000182143
Created by
admin on Sat Dec 16 17:42:55 UTC 2023 , Edited by admin on Sat Dec 16 17:42:55 UTC 2023
|
PRIMARY | P2Y12 Receptor Antagonists [MoA] | ||
|
7150
Created by
admin on Sat Dec 16 17:42:55 UTC 2023 , Edited by admin on Sat Dec 16 17:42:55 UTC 2023
|
PRIMARY | |||
|
SUB13395MIG
Created by
admin on Sat Dec 16 17:42:55 UTC 2023 , Edited by admin on Sat Dec 16 17:42:55 UTC 2023
|
PRIMARY | |||
|
DTXSID6022848
Created by
admin on Sat Dec 16 17:42:55 UTC 2023 , Edited by admin on Sat Dec 16 17:42:55 UTC 2023
|
PRIMARY | |||
|
708
Created by
admin on Sat Dec 16 17:42:55 UTC 2023 , Edited by admin on Sat Dec 16 17:42:55 UTC 2023
|
PRIMARY | |||
|
Clopidogrel
Created by
admin on Sat Dec 16 17:42:55 UTC 2023 , Edited by admin on Sat Dec 16 17:42:55 UTC 2023
|
PRIMARY | |||
|
37941
Created by
admin on Sat Dec 16 17:42:55 UTC 2023 , Edited by admin on Sat Dec 16 17:42:55 UTC 2023
|
PRIMARY | |||
|
A74586SNO7
Created by
admin on Sat Dec 16 17:42:55 UTC 2023 , Edited by admin on Sat Dec 16 17:42:55 UTC 2023
|
PRIMARY | |||
|
A74586SNO7
Created by
admin on Sat Dec 16 17:42:55 UTC 2023 , Edited by admin on Sat Dec 16 17:42:55 UTC 2023
|
PRIMARY | |||
|
32968
Created by
admin on Sat Dec 16 17:42:55 UTC 2023 , Edited by admin on Sat Dec 16 17:42:55 UTC 2023
|
PRIMARY | RxNorm | ||
|
C61686
Created by
admin on Sat Dec 16 17:42:55 UTC 2023 , Edited by admin on Sat Dec 16 17:42:55 UTC 2023
|
PRIMARY | |||
|
60606
Created by
admin on Sat Dec 16 17:42:55 UTC 2023 , Edited by admin on Sat Dec 16 17:42:55 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE |
UGT2B17 has a major role in the intestinal metabolism of clopidogrel.
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET -> INHIBITOR |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
UGT2B7 is the main enzyme involved in clopidogrel carboxylic acid glucuronidation in the liver
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
|
||
|
METABOLITE INACTIVE -> PARENT |
IN-VITRO
Scientific Literature
|
||
|
METABOLITE ACTIVE -> PARENT |
|
||
|
METABOLITE INACTIVE -> PARENT |
|
||
|
METABOLITE ACTIVE -> PRODRUG |
IN-VIVO
PLASMA
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
ORAL BIOAVAILABILITY | PHARMACOKINETIC |
|
|
|||
Tmax | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
THIOL DERIVATIVE PHARMACOKINETIC |
|
||